Thyrocare Technologies Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹542.4
- Today's High:
- ₹573.5
- Open Price:
- ₹571.55
- 52W Low:
- ₹401.1634
- 52W High:
- ₹741.5738
- Prev. Close:
- ₹570.3
- Volume:
- 18023
Company Statistics
- Market Cap.:
- ₹24.29 billion
- Book Value:
- 68.749
- Revenue TTM:
- ₹3.80 billion
- Operating Margin TTM:
- 27.35%
- Gross Profit TTM:
- ₹2.60 billion
- Profit Margin:
- 16.11%
- Return on Assets TTM:
- 18.62%
- Return on Equity TTM:
- 0%
Company Profile
Thyrocare Technologies Ltd had its IPO on under the ticker symbol THYROCARE.
The company operates in the Healthcare sector and Diagnostics & Research industry. Thyrocare Technologies Ltd has a staff strength of 0 employees.
Stock update
Shares of Thyrocare Technologies Ltd opened at ₹571.55 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹542.4 - ₹573.5, and closed at ₹546.35.
This is a -4.2% slip from the previous day's closing price.
A total volume of 18,023 shares were traded at the close of the day’s session.
In the last one week, shares of Thyrocare Technologies Ltd have increased by +1.62%.
Thyrocare Technologies Ltd's Key Ratios
Thyrocare Technologies Ltd has a market cap of ₹24.29 billion, indicating a price to book ratio of 6.6074 and a price to sales ratio of 6.0199.
In the last 12-months Thyrocare Technologies Ltd’s revenue was ₹3.80 billion with a gross profit of ₹2.60 billion and an EBITDA of ₹1.37 billion. The EBITDA ratio measures Thyrocare Technologies Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Thyrocare Technologies Ltd’s operating margin was 27.35% while its return on assets stood at 18.62% with a return of equity of 0%.
In Q4, Thyrocare Technologies Ltd’s quarterly earnings growth was a negative -99.2% while revenue growth was a negative 48.7%.
Thyrocare Technologies Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 40.7308
- PEG
Its diluted EPS in the last 12-months stands at ₹11.317 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Thyrocare Technologies Ltd’s profitability.
Thyrocare Technologies Ltd stock is trading at a EV to sales ratio of 6.2067 and a EV to EBITDA ratio of 21.3161. Its price to sales ratio in the trailing 12-months stood at 6.0199.
Thyrocare Technologies Ltd stock pays annual dividends of ₹5 per share, indicating a yield of 1.07% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹6.01 billion
- Total Liabilities
- ₹711.30 million
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Thyrocare Technologies Ltd ended 2024 with ₹6.01 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹6.01 billion while shareholder equity stood at ₹5.14 billion.
Thyrocare Technologies Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹711.30 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹1.00 billion in goodwill. Its cash balance stood at ₹78.90 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Thyrocare Technologies Ltd’s total current assets stands at ₹2.46 billion while long-term investments were ₹0 and short-term investments were ₹1.13 billion. Its net receivables were ₹891.30 million compared to accounts payable of ₹321.30 million and inventory worth ₹248.90 million.
In 2024, Thyrocare Technologies Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Thyrocare Technologies Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹546.35
- 52-Week High
- ₹741.5738
- 52-Week Low
- ₹401.1634
- Analyst Target Price
- ₹
Thyrocare Technologies Ltd stock is currently trading at ₹546.35 per share. It touched a 52-week high of ₹741.5738 and a 52-week low of ₹741.5738. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹556.37 and 200-day moving average was ₹513.64 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7191.3% of the company’s stock are held by insiders while 2393.9% are held by institutions.
Frequently Asked Questions About Thyrocare Technologies Ltd
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. The company operates through Diagnostic Testing Services, Imaging Services, and Others segments. It conducts medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include 54 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; and radio-pharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India.